U.S., March 21 -- ClinicalTrials.gov registry received information related to the study (NCT07484776) titled 'Metabolic Flexibility in Patients With Early Triple-negative Breast Cancer' on Feb. 27.
Brief Summary: Cancer is considered a major global public health problem. It was estimated that in 2022 approximately 19.9 million new cancer cases were diagnosed worldwide, and this number is expected to increase over the next two decades to 28.0 million (1). Specifically, breast cancer (BC) represents the highest incidence worldwide, with approximately 2.3 million new cases diagnosed in 2022 (1).
A higher incidence of BC is observed in developed countries, which may be due to high rates of obesity, alcohol and tobacco consumption, early onset...